Tech Company Financing Transactions

Bayhill Therapeutics Funding Round

On 5/4/2005, Bayhill Therapeutics raised $35.4 million in Series B financing from De Novo Ventures, Lilly Ventures and Latterell Venture Partners.

Transaction Overview

Announced On
5/4/2005
Transaction Type
Venture Equity
Amount
$35,400,000
Round
Series B
Investors
Proceeds Purpose
This financing supports the development of our lead product candidate currently in phase I, BHT-3009, an antigen-specific drug for treating multiple sclerosis, through Phase II clinical testing

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1804 Embarcadero Rd. 201
Palo Alto, CA 94303
USA
Email Address
Overview
Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases.
Profile
Bayhill Therapeutics LinkedIn Company Profile
Social Media
Bayhill Therapeutics Company Twitter Account
Company News
Bayhill Therapeutics News
Facebook
Bayhill Therapeutics on Facebook
YouTube
Bayhill Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Operating Officer
Hideki Garren
  Hideki Garren LinkedIn Profile  Hideki Garren Twitter Account  Hideki Garren News  Hideki Garren on Facebook
VP - Finance
Kwang Lee
  Kwang Lee LinkedIn Profile  Kwang Lee Twitter Account  Kwang Lee News  Kwang Lee on Facebook
VP - Manufacturing
Robert King
  Robert King LinkedIn Profile  Robert King Twitter Account  Robert King News  Robert King on Facebook
VP - Regulatory Affairs
Joanne Quan
  Joanne Quan LinkedIn Profile  Joanne Quan Twitter Account  Joanne Quan News  Joanne Quan on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/4/2005: Mazor Robotics venture capital transaction
Next: 5/4/2005: High Throughput Genomics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary